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Abstract
Background: The purpose of this study is to compare the performance of three-dimensional magnetic resonance
cholangiopancreatography (3D-MRCP) with non-MRCP T2-weighted magnetic resonance imaging (MRI) sequences
for diagnosis of pancreas divisum (PD).
Methods: This is a retrospective study of 342 consecutive patients with abdominal MRI including 3D-MRCP. 3D-
MRCP was a coronal respiration-navigated T2-weighted sequence with 1.5 mm slice thickness. Non-MRCP T2-
weighted sequences were (1) a coronal inversion recovery sequence (TIRM) with 6 mm slice thickness and (2) a
transverse single shot turbo spin echo sequence (HASTE) with 4 mm slice thickness. For 3D-MRCP, TIRM, and HASTE,
presence of PD and assessment of evaluability were determined in a randomized manner. A consensus read by two
radiologists using 3D-MRCP, non-MRCP T2-weighted sequences, and other available imaging sequences served as
reference standard for diagnosis of PD. Statistical analysis included performance analysis of 3D-MRCP, TIRM, and
HASTE and testing for noninferiority of non-MRCP T2-weighted sequences compared with 3D-MRCP.
Results: Thirty-three of 342 patients (9.7%) were diagnosed with PD using the reference standard. Sensitivity/
specificity of 3D-MRCP for detecting PD were 81.2%/69.7% (p < 0.001). Sensitivity/specificity of TIRM and HASTE
were 92.5%/93.9 and 98.1%/97.0%, respectively (p < 0.001 each). Grouped sensitivity/specificity of non-MRCP T2-
weighted sequences were 99.8%/91.0%. Non-MRCP T2-weighted sequences were non-inferior to 3D-MRCP alone for
diagnosis of PD. 20.2, 7.3%, and 2.3% of 3D-MRCP, TIRM, and HASTE, respectively, were not evaluable due to motion
artifacts or insufficient duct depiction.
Conclusions: Non-MRCP T2-weighted MRI sequences offer high performance for diagnosis of PD and are
noninferior to 3D-MRCP alone.
Trial registration: Not applicable.
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Background
Anatomic anomalies of the pancreas can be classified
as either fusion anomaly (pancreas divisum), migra-
tion anomaly (annular pancreas, ectopic pancreas), or
duplication anomaly (number or form variation). Pan-
creatic fusion and migration anomalies may result in
a predisposition to specific pancreatic or peripancrea-
tic diseases [1]. Pancreas divisum (PD) is the most
common congenital anomaly, occurring in 4 to 14%
of the population according to autopsy studies [1]. It
is the result of a failure of the ventral and dorsal
pancreatic anlagen to fuse during the fifth week of
embryologic development. Consequently, the dorsal
duct drains most of the pancreatic glandular tissue
via the minor papilla [1]. PD is associated with acute
and recurrent pancreatitis. The frequency of PD in
patients with idiopathic pancreatitis is being reported
to reach up to 50% [2, 3].
Endoscopic retrograde cholangiopancreatography (ERCP)
was the modality of choice for diagnosing pancreas
divisum, but is an invasive technique that is associated with
radiation exposure and procedure-related complications
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such as post-ERCP-pancreatitis [4]. To reduce the ERCP
complication rate, cannulation of the pancreatic duct is
avoided if the biliary duct system is the focus of the
examination (ERC).
Nowadays, magnetic resonance cholangiopancreato-
graphy (MRCP) is a well-established noninvasive and
per se complication-free examination for many pan-
creaticobiliary conditions including PD that makes
use of heavily T2-weighted pulse sequences to depict
the fluid-containing pancreaticobiliary duct system
[5]. Three-dimensional MRCP (3D-MRCP) using fast
spin echo pulse sequences with (near) isotropic spatial
resolution and synchronization to respiration repre-
sents the most elaborate MRCP technique currently
used in clinical routine [5]. Despite synchronization
to respiration, however, prolonged acquisition times
of 3D-MRCP may lead to suboptimal image quality
due to motion artifacts especially in non-cooperative
patients, and limited anatomical coverage may hamper
the diagnostic capability of the sequence [6–8].
The so-called one-stop-shop MRI combines dedi-
cated MRCP sequence protocols with other routine
T2-weighted imaging sequences such as half Fourier
acquisition single shot turbo spin echo sequences
(HASTE) and inversion recovery turbo spin echo
sequences (TIRM) for complete abdominal imaging
work-up. These T2-weighted imaging sequences pro-
vide high signal intensity of structures containing
water-bound protons and allow for assessment of
focal lesions and fluid collections but also of the pan-
creaticobiliary system. Each slice is being obtained in
approximately one second so that these techniques
are known to be relatively insensitive to motion arti-
facts [9]. [10].
The primary objective of this study was to test whether
non-MRCP T2-weighted MRI sequences alone or in
combination are noninferior to 3D-MRCP in the diagno-
sis of PD. Secondary objectives were to analyze sensitiv-
ity and specificity of non-MRCP T2-weighted MRI
sequences and 3D-MRCP for the diagnosis of PD.
Methods
Study design
This is a retrospective single center exploratory study
on patients referred to standard 3D-MRCP without
secretin enhancement at our institution between
October 2016 and August 2017. The study was
approved by the institutional review board, and
informed consent was waived. Inclusion criteria were
age of at least 18 years and availability of MRCP as a
part of the individuals’ standard abdominal MRI
work-up. Exclusion criteria were history of pancreati-
cobiliary surgery (excluding cholecystectomy) and
incomplete MRI protocol lacking one or more of the
sequences regularly included in the exam (see below).
For patients who received more than one MRI with
3D-MRCP during the study period, only the first
examination was considered.
Imaging
All MRI examinations were performed using a 1.5 T
scanner (Magnetom AvantoFit, Siemens Healthcare, Er-
langen, Germany). Patients fasted at least 6 h before the
examination. Oral contrast and spasmolytic medication
were not administered.
Technical parameters of 3D-MRCP and non-MRCP
T2-weighted sequences are summarized in Table 1.
3D-MRCP was a three-dimensional respiration-navigated
T2-weighted turbo spin echo sequence in coronal orienta-
tion with a slice thickness of 1.5 mm. Non-MRCP
T2-weighted sequences were: First, a multi-breathhold
TIRM in coronal orientation with a slice thickness of 6
mm. Second, a multi-breathhold HASTE in transverse
orientation with a slice thickness of 4mm.
Other sequences in the MRI protocol were: First, a
pre-contrast T1-weighted three-dimensional fast low
angle shot volumetric interpolated breath-hold examin-
ation with controlled aliasing in parallel imaging (VIBE--
CAIPIRINHA) and Dixon technique for fat suppression
in transverse orientation (slice thickness, 3 mm). Second,
pre- and post-contrast (arterial phase, portal-venous
phase, delayed phase) VIBE-CAIPIRINHA with spectral
fat suppression in transverse orientation (slice thickness,
3 mm). Gadopentetate-Dimeglumine (Gadovist, Bayer
Healthcare, Berlin, Germany) was administered at a dose
of 0.1 mmol/kg body weight and a flow rate of 2 ml/s,
followed by a 30 ml saline flush using a power injector.
Image analysis
Images were analyzed using a picture archiving and
communication system. 3D-MRCP, TIRM, and HASTE
were assessed for presence of PD independently in a ran-
domized manner by a single radiologist (reader 1). A
panel consensus on presence of PD reached by two radi-
ologists (reader 1 and reader 2) using the combination
of 3D-MRCP, TIRM, HASTE, and the above mentioned
other imaging sequences together was defined as the
standard of reference. Reader 1 and reader 2 had 4 years
and 12 years of experience in abdominal imaging,
respectively, and were blinded to clinical information.
Disagreement between two radiologists was managed by
discussion.
PD was deemed to be present when the dorsal pancre-
atic duct crossed the common bile duct, opened into the
duodenum via the minor papilla, and was separated
from a smaller ventral duct.
If assessment of the pancreatic duct anatomy was not
possible, it was assessed whether this was attributable
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either to motion artifacts or to insufficient duct visibility
on images not compromised by motion artifacts. Image
quality was determined by assessing the general magni-
tude of motion artifacts present on each image series
and was subjectively scored using a Likert scale ranging
from 0 (no artifacts) to 3 (severe artifacts).
Statistical analysis
All statistics were calculated using IBM SPSS Statistics
release 23 (Statistical Package for the Social Sciences,
IBM Corporation, Armonk, USA). The diagnostic per-
formance of 3D-MRCP, TIRM, and HASTE for diagnosis
of PD was determined in comparison with the standard
of reference including sensitivity, specificity, and nega-
tive predictive value. A noninferiority test was performed
to analyze similarity between 3D-MRCP on the one
hand and HASTE and TIRM on the other hand for diag-
nosis of PD. Noninferiority was assumed if the sensitivity
of the test method (non-MRCP T2-weighted sequences,
PT) was not worse than the sensitivity of the comparator
method (3D-MRCP, PC) by using a 1-sided test with a
noninferiority margin of Δ. The primary hypothesis can
be stated as H0: PT − PC ≤ −Δ. Noninferiority of PT to
PC is inferred when the lower bound of either confi-
dence interval (CI) is above the noninferiority margin
(−Δ) [11]. The margin Δ was defined to be 0.5 on the
basis of the population and was confirmed by clinical es-
timates from prior research and institutional pilot data.
Image quality assessments were compared between
sequence protocols using paired t-tests.
Results
Study population
During the study period, in 436 consecutive patients
abdominal MRI including 3D-MRCP was performed.
Eighty-eight patients had to be excluded due to history
of pancreatobiliary surgery. Six patients had to be ex-
cluded due to incomplete MRI protocol. Thus, in total
342 patients were available for analysis (sex, 170 females;
mean age, 51 ± 16 years). MRI with 3D-MRCP was per-
formed for a variety of clinical indications, which are
summarized in Table 2. Pancreatic findings observed in
the study patients are summarized in Table 3.
Acquisition times
Mean acquisition time of 3D-MRCP was 176 ± 66 s. Ac-
quisition times per sequence protocol design were 55 s
and 74 s for TIRM and HASTE, respectively.
Assessment of PD
Thirty-three of 342 patients (9.7%) were diagnosed with
PD using the standard of reference.
Sensitivity and specificity of 3D-MRCP for diagnosing
PD was 81.2 and 69.7% (p < 0.001). Sensitivity and
specificity of TIRM for diagnosing PD was 92.5 and
93.9% (p < 0.001). Sensitivity and specificity of HASTE
for diagnosing PD was 98.1 and 97.0% (p < 0.001).
Grouped sensitivity and specificity of the combination of
non-MRCP T2-weighted sequences was 99.8 and 91.0%.
The negative predictive value of the combination of
non-MRCP T2-weighted sequences was 99.9%.
Both TIRM alone (lower bound of 95% CI -0.03) and
HASTE alone (lower bound of 95% CI 0.3) as well as the
combination of TIRM and HASTE (lower bound of 95%
CI 0.06) were noninferior to 3D-MRCP (lower bound of
95% CI -0.3) for diagnosis of PD (Fig. 1).
Image quality
The mean general magnitude of motion artifacts was
scored with 1.07 ± 0.86, 0.03 ± 0.19, and 0.10 ± 0.33 for
3D-MRCP, TIRM, and HASTE. The artifact scoring was
better for both TIRM and HASTE than for 3D-MRCP
(p < 0.001, each).
Assessment of pancreatic duct orifice anatomy was
not possible in 20.2% (69/342), 7.3% (25/342), and 2.3%
(8/342) of 3D-MRCP, TIRM, and HASTE, respectively.
This was due to motion artifacts in 9.4% (32/342), 0.3%
(1/342), and 0.0% (0/342) and due to insufficient duct
Table 1 Technical parameters of 3D-MRCP and non-MRCP T2-weighted sequences
3D-MRCP TIRM HASTE
Orientation Coronal Coronal Transverse
Voxel size [mm] 0.9 × 0.9 × 1.5 1.0 × 1.0 × 6.0 1.2 × 1.2 × 4.0
Distance factor 50% 10% 10%
TR [ms] 2000 1000 1400
TE [ms] 686 79 93
Parallel imaging (acceleration factor) GRAPPA (3) GRAPPA (2) none
Table 2 Clinical indications for MRI with MRCP
Extrapancreatic tumor Extrapancreatic non-oncological disease Intrapancreatic tumor Intrapancreatic inflammatory disease Other
n 20 69 112 137 4
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depiction in 10.8% (37/342), 7.0% (24/342), and 2.3% (8/
342) of 3D-MRCP, TIRM, and HASTE, respectively.
Figures 2 and 3 show representative examples of PD
diagnosis in a patient with 3D-MRCP without artifacts
(Fig. 2) and in a patient with 3D-MRCP with severe arti-
facts (Fig. 3).
Discussion
The results of our study indicate that non-MRCP
T2-weighted sequences frequently included in routine
abdominal MRI protocols not primarily focusing on pan-
creatic duct visualization have high diagnostic perform-
ance for diagnosis of PD, are noninferior to dedicated
3D-MRCP concerning PD diagnosis, and are less prone
to motion artifacts than 3D-MRCP.
PD is the most common anatomic variant of the pan-
creas. The frequency of PD observed in our study is
comparable to previous reports [12]. PD can be diag-
nosed on imaging studies when the dorsal pancreatic
duct crosses the common bile duct anteriorly with a
constant caliber, opens into the duodenum via the
minor papilla, and is separated from a smaller ventral
duct [13].
Aside from PD there are other anatomic variants in
which pancreatic duct drainage via the minor papilla can
be seen. These include a patent minor papilla and in-
complete PD [13]. Opposed to the PD definition men-
tioned above and used in this study, a patent minor
papilla is considered to be present if the dominant
pancreatic duct drains via the major papilla and a
smaller pancreatic duct drains via the minor papilla. In
incomplete PD, there is a visible connection between the
dominant duct that drains via the minor papilla and the
smaller ventral duct that drains via the major papilla.
Data indicate that clinical presentation and symptom
occurrence rate of incomplete PD and complete PD are
similar, so that we did not aim to differentiate between
these two closely related variants [14, 15].
The non-MRCP sequences used in our study to assess
presence of PD are standard T2-weighted sequences
generally recommended to be part of abdominal MRI
[9]. T2-weighted imaging sequences are of special use
for characterization of fluid containing structures. Some
studies have shown their value especially for pancreatic
cystic lesions. Pozzi-Mucelli et al. have demonstrated
that an abbreviated pancreas MRI only including a
transverse and coronal HASTE with a slice thickness of
4 mm is similar to a comprehensive protocol including
3D-MRCP for diameter assessment of cystic pancreatic
masses [16]. Macari et al. reported that using a MRI
protocol based on HASTE and TIRM sequences one
could abstain from contrast administration for follow-up
of pancreatic cystic lesions [17]. Chalazonitis et al. de-
scribe one case of incomplete pancreas divisum, in that
findings were more evident on HASTE images than on
dedicated MRCP images [18].
The diagnostic performance of MRCP for detection of
PD reported in the literature varies and is in part
Table 3 Pancreatic findings
Unremarkable pancreas Cystic lesions≥ 10 mm Cystic lesions < 10 mm Signs of pancreatitis Other
n 169 59 74 63 10
Fig. 1 Non-inferiority test comparing 3D-MRCP with TIRM and HASTE
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depending on the MRCP technique used. In an older
study by Bret et al., MRCP was able to detect PD in all
patients that were diagnosed with PD in ERCP [19]. In
another older study by Ueno et al., sensitivity of MRCP
for PD diagnosis was below 50% [20]. Newer studies re-
port on sensitivities of MRCP for PD diagnosis that lie
in between of these values, e.g. Carnes et al. [21], Mosler
et al. [6] or Kushnir et al. [22]. Carnes et al. discussed
that suboptimal MRI techniques and reader inexperience
are relevant contributing factors to miss PD diagnosis
[21]. Although synchronized to respiration, our data
show that 3D-MRCP is still prone to motion artifacts in
clinical routine in patients with limited capability for
shallow constant breathing.
Other frequently used MRCP techniques are two-
dimensional sequence protocols that can be performed
as a thick slab acquisition with slice thicknesses from 40
to 60mm or as multiple thinner slices (less than 5mm)
during breath-holding. Thick slab MRCP represents a
summation image of the scanned volume that hampers
spatial mapping of findings and, thus, may suggest
anatomical relationships that may not be present.
Although two-dimensional MRCP sequences are faster
than 3D-MRCP and have a role in assessing pancreatic
Fig. 2 Pancreas divisum in 3D-MRCP. (a), TIRM (b), and HASTE (c). 3D-MRCP with good overall image quality and TIRM and HASTE show the main
pancreatic duct (MD) crossing the bile duct (BD) cranially and opening via the minor papilla
Fig. 3 Pancreas divisum in 3D-MRCP. (a), TIRM (b), and HASTE (c). 3D-MRCP has poor overall image quality and does not show pancreas divisum.
TIRM and HASTE clearly indicate presence of PD
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duct anatomy, thick slab MRCP is not part of the MRI
protocol used in this study, because its diagnostic value
in evaluating pancreaticobiliary disease can be discussed
controversially and was frequently shown to be inferior
to 3D-MRCP [23–27].
Negative oral contrast agents are suggested to be used
especially in thick slab MRCP to eliminate signal from
overlapping fluid-containing bowel [10] or may improve
the informative value of maximum intensity projections
(MIP) reconstructed from 3D-MRCP. Since in our study
not MIPs but the original slices of 3D-MRCPs were ana-
lyzed, we believe that not using negative oral contrast
does not impact negatively on duct assessment.
Publications have suggested that PD diagnosis by
MRCP can be facilitated after intravenous administration
of secretin to stimulate pancreatic excretion [28]. How-
ever, data on secretin-enhanced MRCP concerning PD
diagnosis are ambiguous [21]. Thus, at our institution
secretin is only used in special cases when functional
information on pancreatic juice secretion is needed
(pancreatic insufficiency, papilla stenosis).
Limitations
There are limitations to our study. ERCP as the historical
gold standard for assessment of pancreaticobiliary duct
anatomy was not available in our patients, and we used a
combination of all available image series to define the
ground truth. Nowadays, the mainstay of endoscopic proce-
dures is depicting the pancreatic and biliary system in
patients with high pretest probability for necessity of a sim-
ultaneous endoscopic therapeutic procedure and are, thus,
frequently limited to ERC to reduce complication rates.
Taking this into account, MRCP techniques may be consid-
ered the de facto gold standard for assessing the pancreatic
duct anatomy. Endosonography represents an endoscopic
alternative to ERCP for PD assessment [29]. In the absence
of a non-invasive reference standard for PD diagnosis differ-
ent from MRI, all available imaging sequences including the
investigational sequences were used to determine ground
truth. This may lead to an incorporation bias resulting in
potential overestimation of the diagnostic test’s accuracy.
We only performed a single-reader analysis for assessment
of PD and a two-person consensus panel defined the refer-
ence standard. Thus, information on reproducibility and
inter-rater variability of our data cannot be inferred. As the
number of cases positive for PD in our study is low, the re-
sults should be confirmed in a larger prospective trial.
Conclusion
Non-MRCP T2-weighted MRI sequences usually in-
cluded in standard abdominal MRI protocols are nonin-
ferior to 3D-MRCP alone in regards of correctly
diagnosing PD. It may not be necessary to perform
3D-MRCP to assess pancreatic duct orifice anatomy.
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